18.Surgical Management of Idiopathic Trigeminal Neuralgia Using Spongiston A Single Centre Study
Naeem Ul Haq1, Syed Nasir Shah1, Gohar Ali1, Mian Iftikhar Ul Haq2, Musawer Khan1 and Inayat Shah1
ABSTRACT
Objective: A study of the effectiveness of micro vascular decompression as a therapy for trigeminal neuralgia.
Study Design: A single-center study
Place and Duration of Study: This study was conducted at the Neurosurgery departments of Bacha Khan Medical College/Mardan Medical Complex in Mardan from January, 2021 to July, 2021.
Materials and Methods: This study included 34 individuals of both genders who presented with trigeminal neuralgia. Following written permission, the patient's complete demographics were collected. Micro-vascular decompression was performed on all patients. Borrow Neurological Institute Pain score was used to measure outcomes (BNIP). On the fifth postoperative day, a check-up was performed. SPSS 24.0 was used to analyze
the data.
Results: Patients' average age was 54.269.78 years old. Out of a total of 42 people, 20 were female (58.82%) and 14 were male (41.17%). Seventeen patients (50%) recovered completely after surgery with a BNIP score of 1-2 and no medication, twelve patients (35.29%) recovered partially with a BNIP score of 3, and five patients (14.71%) did not recover at all with a BNIP score of 4. It may be concluded that micro-vascular decompression is an effective and safe treatment for trigeminal neuralgia with a negligible risk of complications.
Conclusion: Trigeminal neuralgia is one of the most painful neurological disorders. Micro-vascular decompression is an effective and safe treatment for trigeminal neuralgia, with fewer adverse events and higher patient satisfaction levels than alternative options. On average, 90 percent relieved with surgical treatment.
Key Words: Micro-vascular Decompression (MVD), Trigeminal Neuralgia, Effectiveness
Citation of article: Naeem Ul Haq, Shah SN, Ali G, Iftikhar Ul Haq M, Khan M, Shah I. Surgical Management of Idiopathic Trigeminal Neuralgia Using Spongiston A Single Centre Study. Med Forum 2022;33(10):81-83.